Summary of performance comparison with other existing methods in the second stage
| Cancer type . | Method . | Accuracy . | Precision . | Recall (=TPR) . | F1-score . | FPR . |
|---|---|---|---|---|---|---|
| Breast | ACP-MLC | 93.33% | 92.12% | 92.72% | 92.42% | 13.04% |
| ACP-CapsPred | 94.59% | 96.08% | 96.08% | 96.08% | 3.92% | |
| Lung | ACP-MLC | 55.55% | 55.55% | 100.00% | 71.42% | 85.47% |
| ACP-CapsPred | 82.43% | 85.14% | 82.05% | 83.57% | 11.42% | |
| Colon | ACP-MLC | 91.89% | 96.07% | 92.45% | 94.23% | 10.71% |
| ACP-CapsPred | 91.60% | 90.83% | 92.16% | 91.49% | 8.92% | |
| Cervical | ACP-MLC | 49.31% | 51.35% | 50.00% | 50.66% | 8.33% |
| ACP-CapsPred | 94.59% | 92.11% | 97.22% | 94.60% | 2.77% | |
| Skin | ACP-MLC | 71.16% | 67.00% | 84.47% | 74.73 % | 41.18% |
| ACP-CapsPred | 90.54% | 90.00% | 92.31% | 91.14% | 11.42% | |
| Average | ACP-MLC | 72.25% | 72.42% | 83.93% | 76.69% | 31.74% |
| ACP-CapsPred | 90.75% | 90.83% | 91.96% | 91.38% | 7.69% |
| Cancer type . | Method . | Accuracy . | Precision . | Recall (=TPR) . | F1-score . | FPR . |
|---|---|---|---|---|---|---|
| Breast | ACP-MLC | 93.33% | 92.12% | 92.72% | 92.42% | 13.04% |
| ACP-CapsPred | 94.59% | 96.08% | 96.08% | 96.08% | 3.92% | |
| Lung | ACP-MLC | 55.55% | 55.55% | 100.00% | 71.42% | 85.47% |
| ACP-CapsPred | 82.43% | 85.14% | 82.05% | 83.57% | 11.42% | |
| Colon | ACP-MLC | 91.89% | 96.07% | 92.45% | 94.23% | 10.71% |
| ACP-CapsPred | 91.60% | 90.83% | 92.16% | 91.49% | 8.92% | |
| Cervical | ACP-MLC | 49.31% | 51.35% | 50.00% | 50.66% | 8.33% |
| ACP-CapsPred | 94.59% | 92.11% | 97.22% | 94.60% | 2.77% | |
| Skin | ACP-MLC | 71.16% | 67.00% | 84.47% | 74.73 % | 41.18% |
| ACP-CapsPred | 90.54% | 90.00% | 92.31% | 91.14% | 11.42% | |
| Average | ACP-MLC | 72.25% | 72.42% | 83.93% | 76.69% | 31.74% |
| ACP-CapsPred | 90.75% | 90.83% | 91.96% | 91.38% | 7.69% |
Summary of performance comparison with other existing methods in the second stage
| Cancer type . | Method . | Accuracy . | Precision . | Recall (=TPR) . | F1-score . | FPR . |
|---|---|---|---|---|---|---|
| Breast | ACP-MLC | 93.33% | 92.12% | 92.72% | 92.42% | 13.04% |
| ACP-CapsPred | 94.59% | 96.08% | 96.08% | 96.08% | 3.92% | |
| Lung | ACP-MLC | 55.55% | 55.55% | 100.00% | 71.42% | 85.47% |
| ACP-CapsPred | 82.43% | 85.14% | 82.05% | 83.57% | 11.42% | |
| Colon | ACP-MLC | 91.89% | 96.07% | 92.45% | 94.23% | 10.71% |
| ACP-CapsPred | 91.60% | 90.83% | 92.16% | 91.49% | 8.92% | |
| Cervical | ACP-MLC | 49.31% | 51.35% | 50.00% | 50.66% | 8.33% |
| ACP-CapsPred | 94.59% | 92.11% | 97.22% | 94.60% | 2.77% | |
| Skin | ACP-MLC | 71.16% | 67.00% | 84.47% | 74.73 % | 41.18% |
| ACP-CapsPred | 90.54% | 90.00% | 92.31% | 91.14% | 11.42% | |
| Average | ACP-MLC | 72.25% | 72.42% | 83.93% | 76.69% | 31.74% |
| ACP-CapsPred | 90.75% | 90.83% | 91.96% | 91.38% | 7.69% |
| Cancer type . | Method . | Accuracy . | Precision . | Recall (=TPR) . | F1-score . | FPR . |
|---|---|---|---|---|---|---|
| Breast | ACP-MLC | 93.33% | 92.12% | 92.72% | 92.42% | 13.04% |
| ACP-CapsPred | 94.59% | 96.08% | 96.08% | 96.08% | 3.92% | |
| Lung | ACP-MLC | 55.55% | 55.55% | 100.00% | 71.42% | 85.47% |
| ACP-CapsPred | 82.43% | 85.14% | 82.05% | 83.57% | 11.42% | |
| Colon | ACP-MLC | 91.89% | 96.07% | 92.45% | 94.23% | 10.71% |
| ACP-CapsPred | 91.60% | 90.83% | 92.16% | 91.49% | 8.92% | |
| Cervical | ACP-MLC | 49.31% | 51.35% | 50.00% | 50.66% | 8.33% |
| ACP-CapsPred | 94.59% | 92.11% | 97.22% | 94.60% | 2.77% | |
| Skin | ACP-MLC | 71.16% | 67.00% | 84.47% | 74.73 % | 41.18% |
| ACP-CapsPred | 90.54% | 90.00% | 92.31% | 91.14% | 11.42% | |
| Average | ACP-MLC | 72.25% | 72.42% | 83.93% | 76.69% | 31.74% |
| ACP-CapsPred | 90.75% | 90.83% | 91.96% | 91.38% | 7.69% |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
